Accredited Continuing Education

American College of Healthcare Executives

By attending The Academy for Healthcare Leadership Advancement offered by the Healthcare Association of New York State, participants may earn up to 34.75 ACHE Qualified Education Hours toward initial certification or recertification of the FACHE designation.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and HANYS. AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education, Accreditation Council for Pharmacy Education and American Nurses Credentialing Center to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive a maximum of 23.5 Interprofessional Continuing Education credit for learning and change.

Credit Designation for Physicians

AXIS Medical Education designates this live activity for a maximum of 23.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Designation for Nursing

AXIS Medical Education designates this continuing nursing education activity for 23.5 contact hours.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Quality Professionals

This program has been approved by the National Association for Healthcare Quality for a maximum of 6.25 CPHQ continuing education credits.

AXIS Contact Information

For information about the accreditation of this program, please contact AXIS at

Disclosure of Conflicts of Interest

AXIS Medical Education requires faculty, instructors, authors, planners, directors, managers, reviewers and other individuals who are in a position to control the content of this activity to disclose all real or apparent conflicts of interest they may have with ineligible companies. An ineligible entity is any organization whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. All relevant conflicts of interest are identified and mitigated prior to initiation of the planning phase for an activity

AXIS has mitigated and disclosed to learners all relevant conflicts of interest disclosed by staff, planners, faculty/authors, peer reviewers or others in control of content for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation or activity. Disclosure information for faculty, authors, course directors, planners, peer reviewers and/or relevant staff is provided with this activity.

The faculty reported the following relevant financial relationships or relationships they have with ineligible companies of any amount during the past 24 months:

Name of Faculty or PresenterReported Financial Relationship
Victoria AufieroNothing to disclose
Alyssa DahlNothing to disclose
Michelle M. Duguid, PhDNothing to disclose
Steven I. GoldsteinNothing to disclose
Thomas HalliseyNothing to disclose
Cara HenleyNothing to disclose
Helen Arteaga Landaverde, MPHNothing to disclose
Elizabeth A. “Beta” Mannix, PhDNothing to disclose
John B. McCabe, MDNothing to disclose
Colleen McVeighNothing to disclose
Kristen Mucitelli-HeathNothing to disclose
Drew David PascarellaNothing to disclose
Kathleen Rauch, RN, MSHQS, BSN, CPHQNothing to disclose
Stephen Sauer, PhDNothing to disclose
Sandra Scott, MDNothing to disclose
Joseph M. Tasse, FACHENothing to disclose

The directors, planners, managers and reviewers — Allison Manny, CMP; John B. McCabe, MD; Kathy Rauch, RN, MSHQS, BSN, CPHQ; Elizabeth Mannix, PhD; Holly M. Hampe, DSc, RN, MHA, MRM, CPHQ; and Dee Morgillo, MEd, MT(ASCP), CHCP — reported no financial relationships they have with any ineligible company of any amount during the past 24 months.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.

Requirements for credit

Attend/participate in this educational activity and review all course materials.

  • The Attestation portal will activate at the conclusion of the program on Nov. 7, 2023.
  • Complete the CE Attestation form online by 11:59 p.m. ET Dec. 7, 2023. Instructions will be provided. If you do not enter the online portal by this date, you will not be able to retrieve your statement of participation.
  • Upon successful completion of the online form, your statement of completion will be presented to you to print.